Comparable Psychotropic Prescription Rates After Hospital Discharge Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory Infection [0.03%]
出院后新冠肺炎患者和非新冠肺炎呼吸系统感染患者的 psychotropic药物开具处方率可比性研究
Yuna Takahashi,Taisuke Yatomi,Naohito Yamaguchi et al.
Yuna Takahashi et al.
Introduction: Whether psychiatric symptoms after recovery from coronavirus disease 2019 (COVID-19) are specific to this illness remains unclear. Methods: ...
Comparative Study
Pharmacopsychiatry. 2024 Jul;57(4):186-190. DOI:10.1055/a-2286-1427 2024
Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany [0.03%]
不同种类的大麻的药用价值：来自德国一项大规模前瞻性调查的结果
Natalia Szejko,Eva Becher,Florian Heimann et al.
Natalia Szejko et al.
Background: Up to now, it is unclear whether different medicinal cannabis (MC) strains are differently efficacious across different medical conditions. In this study, the effectiveness of different MC strains was compared...
Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature [0.03%]
利培酮引起的白细胞中性粒细胞减少症：阳性再激发证据和文献回顾
Dhouha Sahnoun,Ahlem Ghanmi,Soumaya Gazzeh et al.
Dhouha Sahnoun et al.
Antipsychotics can cause hematologic disorders, and they can have life-threatening consequences. Risperidone, less commonly associated with hematologic adverse effects, is an atypical antipsychotic medication used to treat conditions such a...
Scott Monteith,Tasha Glenn,John R Geddes et al.
Scott Monteith et al.
Online self-diagnosis of psychiatric disorders by the general public is increasing. The reasons for the increase include the expansion of Internet technologies and the use of social media, the rapid growth of direct-to-consumer e-commerce i...
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study [0.03%]
加拿大合法化大麻和医疗大麻项目的背景下，患有情绪障碍和焦虑障碍个体对大麻使用感知、体验与模式的一项定性研究
Ankita Das,Christian S Hendershot,M Ishrat Husain et al.
Ankita Das et al.
Introduction: Perceptions of cannabis as a potential medical treatment for mood and anxiety disorders have been increasing in the context of legalizations, availability, and medical cannabis programs, though current evide...
Barbara Broers,Federica Bianchi
Barbara Broers
Dementia, with loss of memory, cognitive abilities, and independent daily functioning, is increasing worldwide, related to an aging population. Currently, there is no curative treatment for dementia. Treatment of the frequently occurring be...
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature [0.03%]
大麻素在治疗某些精神疾病中的应用：实用方法和文献综述
Kirsten R Müller-Vahl
Kirsten R Müller-Vahl
Although an increasing number of patients suffering from mental illnesses self-medicate with cannabis, current knowledge about the efficacy and safety of cannabis-based medicine in psychiatry is still extremely limited. So far, no cannabis-...
Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis [0.03%]
解开年龄、智商、教育和阴性症状对精神分裂症神经认知表现的影响：条件推断树分析
Xenia M Hart,Yasue Mitsukura,Robert R Bies et al.
Xenia M Hart et al.
Introduction: The complex nature of neurocognitive impairment in schizophrenia has been discussed in light of the mixed effects of antipsychotic drugs, psychotic symptoms, dopamine D2 receptor blockade, and intelligence q...
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics [0.03%]
细胞色素2C19表型效应整合到临床药物遗传学中的相关性问题
Maike Scherf-Clavel,Heike Weber,Stefan Unterecker et al.
Maike Scherf-Clavel et al.
Introduction: CYP2D6 and CYP2C19 functional status as defined by genotype is modulated by phenoconversion (PC) due to pharmacokinetic interactions. As of today, there is no data on the effect size of PC for CYP2C19 functi...
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits - A Critical Review [0.03%]
大麻二酚及其基于证据的精神病益处批判性综述
Inga Dammann,Cathrin Rohleder,F Markus Leweke
Inga Dammann
The endocannabinoid system shows promise as a novel target for treating psychiatric conditions. Cannabidiol (CBD), a naturally occurring cannabinoid, has been investigated in several psychiatric conditions, with diverse effects and an excel...